Arkolith/Insider Trading/INBS/Form 4

Sakiris Spiro Kevin

Chief Financial OfficerINTELLIGENT BIO SOLUTIONS INC. (INBS) · full profile →Form 4 · filed Oct 6, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 4, 2023Buy(P)113K——117K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 4, 2023Buy(P)113K——113K
Oct 4, 2023Buy(P)113K——113K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-23-036581) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML